InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Coen Stacy Ann, Directrice des Affaires. Director active across 1 company, notably ImmunoGen, Inc.. Cumulatively, 14 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €102k. History available since 30 June 2021. The latest transaction was disclosed on 2 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
73,274 sharesCommon StockSEC:0001104659-24-014711:0
14,350 shares0Common StockSEC:0001415889-24-002873:0
30,000 shares@ US$5.3213.6% of flowCommon StockSEC:0001415889-24-000381:0
3,826 shares@ US$29.209.6% of flowCommon StockSEC:0001415889-23-015909:0
20,986 shares@ US$4.929.0% of flowCommon StockSEC:0001415889-23-015268:0
26,006 shares@ US$7.6917.7% of flowCommon StockSEC:0001415889-23-013144:0
100,210 shares@ US$4.9242.4% of flowCommon StockSEC:0001415889-23-012146:0
4,255 shares@ US$4.921.8% of flowCommon StockSEC:0001415889-23-011882:0
3,792 shares@ US$4.051.3% of flowCommon StockSEC:0001415889-23-010825:0
3,342 shares@ US$3.8251.2% of flowCommon StockSEC:0001415889-22-007337:0
1,496 shares@ US$5.600.7% of flowCommon StockSEC:0001179110-22-000102
1,496 shares@ US$5.6020.3% of flowCommon StockSEC:0001179110-22-000102:0
2,330 shares@ US$5.5229.7% of flowCommon StockSEC:0001179110-21-007316:0
2,330 shares@ US$5.521.0% of flowCommon StockSEC:0001179110-21-007316
14 of 14 declarations
About Coen Stacy Ann
Stacy Ann Coen is the Chief Business Officer at ImmunoGen, Inc. She is responsible for the company's business strategy, overseeing growth and development initiatives. Her role is essential for ensuring the success of the organization.
